Published in Nucleic Acids Res on February 11, 1995
Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J (1999) 1.91
Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA. Antimicrob Agents Chemother (2000) 1.12
Molecular mechanics of 30S subunit head rotation. Proc Natl Acad Sci U S A (2014) 1.05
Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae. Front Microbiol (2013) 0.95
The 16S ribosomal RNA mutation database (16SMDB). Nucleic Acids Res (1996) 0.93
Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway. Antimicrob Agents Chemother (2012) 0.89
Mutations in 16S rRNA and ribosomal protein S5 associated with high-level spectinomycin resistance in Pasteurella multocida. Antimicrob Agents Chemother (2007) 0.86
Phenotypic Suppression of Streptomycin Resistance by Mutations in Multiple Components of the Translation Apparatus. J Bacteriol (2015) 0.77
The Loop 2 Region of Ribosomal Protein uS5 Influences Spectinomycin Sensitivity, Translational Fidelity and Ribosome Biogenesis. Antimicrob Agents Chemother (2016) 0.75
Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli. Plasmid (1981) 9.00
Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature (1987) 8.96
Genetic studies of the lac repressor. I. Correlation of mutational sites with specific amino acid residues: construction of a colinear gene-protein map. J Mol Biol (1977) 5.14
Compilation of small ribosomal subunit RNA sequences. Nucleic Acids Res (1991) 5.03
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Higher order structural elements in ribosomal RNAs: pseudo-knots and the use of noncanonical pairs. Proc Natl Acad Sci U S A (1990) 2.75
Antibiotic resistance mutations in the chloroplast 16S and 23S rRNA genes of Chlamydomonas reinhardtii: correlation of genetic and physical maps of the chloroplast genome. Genetics (1989) 2.41
Isolation of temperature-sensitive mutants of 16 S rRNA in Escherichia coli. J Mol Biol (1989) 1.82
Three widely separated positions in the 16S RNA lie in or close to the ribosomal decoding region; a site-directed cross-linking study with mRNA analogues. EMBO J (1992) 1.76
Ribosomal RNA and protein mutants resistant to spectinomycin. EMBO J (1990) 1.75
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Ribosomal Protein Conferring Sensitivity to the Antibiotic Spectinomycin in Escherichia coli. Science (1969) 1.73
Effects of mutagenesis of a conserved base-paired site near the decoding region of Escherichia coli 16 S ribosomal RNA. J Mol Biol (1990) 1.72
beta-Galactosidase chimeras: primary structure of a lac repressor-beta-galactosidase protein. Proc Natl Acad Sci U S A (1978) 1.60
Spectinomycin resistance at site 1192 in 16S ribosomal RNA of E. coli: an analysis of three mutants. Biochimie (1987) 1.57
Mutation proximal to the tRNA binding region of the Nicotiana plastid 16S rRNA confers resistance to spectinomycin. Mol Gen Genet (1991) 1.52
Independent in vitro assembly of a ribonucleoprotein particle containing the 3' domain of 16S rRNA. Proc Natl Acad Sci U S A (1994) 1.43
Spectinomycin interacts specifically with the residues G1064 and C1192 in 16S rRNA, thereby potentially freezing this molecule into an inactive conformation. Nucleic Acids Res (1994) 1.36
Some characteristics of and structural requirements for the interaction of 24,25-dihydrofusidic acid with ribosome - elongation factor g Complexes. Biochemistry (1975) 1.33
RNA-protein interactions in the Escherichia coli ribosome. Biochimie (1992) 1.32
The molecular basis for rRNA-dependent spectinomycin resistance in Nicotiana chloroplasts. EMBO J (1987) 1.22
Mutagenesis at the mRNA decoding site in the 16S ribosomal RNA using the specialized ribosome system in Escherichia coli. EMBO J (1988) 1.20
The third ribosomal tRNA-binding site, the E site, is occupied in native polysomes. Eur J Biochem (1989) 1.15
Spectinomycin resistance due to a mutation in an rRNA operon of Escherichia coli. J Bacteriol (1983) 1.11
In vivo selection of conditional-lethal mutations in the gene encoding elongation factor G of Escherichia coli. J Bacteriol (1994) 1.07
Novel mutants of elongation factor G. J Mol Biol (1990) 0.93
Medical student selection: a tentative attempt to establish a code of practice. Br Med J (1980) 7.21
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science (2000) 4.48
Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A (1998) 4.28
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Consultation length and outcome in two group general practices. J R Coll Gen Pract (1983) 3.76
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
Paper and people: the work of the casualty reception clerk. Sociol Health Illn (1989) 2.54
Prospective analysis of stoma-related complications. Colorectal Dis (2005) 2.35
Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med (1991) 2.34
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol (2001) 2.30
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
Comparison of sevoflurane and propofol with rocuronium for modified rapid-sequence induction of anaesthesia. Anaesthesia (1999) 1.98
Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol (1999) 1.93
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol (1999) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer. J Urol (2011) 1.72
Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 1.69
Head injuries: a study evaluating the impact of the NICE head injury guidelines. Emerg Med J (2005) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A (1996) 1.63
Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol (1979) 1.63
Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med (1982) 1.52
Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc (2006) 1.50
Community health monitoring: taking the pulse of America's children. Matern Child Health J (1998) 1.47
Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet (1968) 1.46
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology (1994) 1.43
Homologous recombination between the tuf genes of Salmonella typhimurium. J Mol Biol (1996) 1.43
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Clinical trial of iron therapy of psychomotor function in anaemic women. Br Med J (1970) 1.41
Low-dose clonidine infusion during labour. Br J Anaesth (1999) 1.40
Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus (1995) 1.39
Benign vaginal polyp: a histological, histochemical and immunohistochemical study of 20 polyps with comparison to normal vaginal subepithelial layer. Histopathology (1992) 1.38
Is midwifery safe in the embrace of the UKCC? Midwives (1995) (1995) 1.38
Sequence heterogeneity and anomalous electrophoretic mobility of kinetoplast minicircle DNA from Leishmania tarentolae. Gene (1984) 1.36
Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36
Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet (1997) 1.36
Phylogenetic characterization of epibiotic bacteria in the accessory nidamental gland and egg capsules of the squid Loligo pealei (Cephalopoda:Loliginidae). Environ Microbiol (2001) 1.31
The effects of cytokines and growth factors on osteoblastic cells. Bone (1995) 1.28
Doctors' and nurses' perceptions of ethical problems in end-of-life decisions. J Adv Nurs (2001) 1.28
Lymphocyte transformation using whole blood cultures: an analysis of responses. J Immunol Methods (1972) 1.26
Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. Br J Surg (2002) 1.25
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer (2012) 1.24
The calibration of a whole-body radioactivity counter for the measurement of body potassium content in clinical studies. Clin Sci (1967) 1.24
A technique for rapid isolation of macrophages from guinea-pig peritoneal exudates. J Clin Pathol (1970) 1.21
Lymphocyte sensitivity to encephalitogenic factor in guinea pigs with experimental allergic encephalomyelitis as shown by in vitro inhibition of macrophage migration. Int Arch Allergy Appl Immunol (1968) 1.21
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer (1972) 1.19
Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD. Int Arch Allergy Appl Immunol (1975) 1.18
Comparison of the traditional paper visual analogue scale questionnaire with an Apple Newton electronic appetite rating system (EARS) in free living subjects feeding ad libitum. Eur J Clin Nutr (1998) 1.18
Macrophages in tissues and in vitro. Curr Opin Immunol (1992) 1.17
Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res (1987) 1.16
Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl (1973) 1.15
On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis. Clin Exp Immunol (1970) 1.15
Growth and translation elongation rate are sensitive to the concentration of EF-Tu. Mol Microbiol (1993) 1.15
Diversifying microbial natural products for drug discovery. Appl Microbiol Biotechnol (2003) 1.13
In-vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response. Klin Wochenschr (1974) 1.13
Anti-macrophage component of antilymphocytic serum. Lancet (1969) 1.12
The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Health Technol Assess (2012) 1.12
Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp. Mol Microbiol (2000) 1.12
Econometric analyses of national health expenditures: can positive economics help to answer normative questions? Health Econ (1993) 1.12
Mutant ribosomes can generate dominant kirromycin resistance. J Bacteriol (1991) 1.11
Lymphocyte sensitivity in cancer. Br Med J (1971) 1.09
Chromosomal assignment of c-MEL, a human transforming oncogene, to chromosome 19 (p13.2-q13.2). Somat Cell Mol Genet (1986) 1.09
A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome. J Bacteriol (1993) 1.09
Toxicity of motor neurone disease serum for myelin in tissue culture. Br Med J (1965) 1.09
Stressful life events and the onset of a generalized anxiety syndrome. Am J Psychiatry (1987) 1.07
The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants. J Mol Biol (1996) 1.07
Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets. Am J Obstet Gynecol (1985) 1.03
Discrepancies between whole-body potassium content and exchangeable potassium. J Lab Clin Med (1968) 1.03
A qualitative study of paramedics' attitudes to providing prehospital thrombolysis. Emerg Med J (2005) 1.03
Effect of prazosin vs placebo on chronic left ventricular heart failure. Circulation (1979) 1.02
Mode of action of antilymphocyte serum. Lancet (1969) 1.02
Macrophage migration inhibition test: a critical examination of the technique using a polythene capillary tubing micromethod. J Immunol Methods (1972) 1.02
RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia (1988) 1.01
Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiol Dis (2006) 1.01
Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharmacol Ther (2009) 1.01
Non-specificity of laboratory test for diagnosis of multiple sclerosis. Br Med J (1974) 0.99
Clinical studies on whole-body potassium content measured by gamma-ray spectrometry in health and disease. Clin Sci (1967) 0.99
Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol (1994) 0.98
The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis. Am Rev Respir Dis (1984) 0.98
Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax (2000) 0.98
Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section. Br J Anaesth (1996) 0.97
Suppression of rpsL phenotypes by tuf mutations reveals a unique relationship between translation elongation and growth rate. Mol Microbiol (1993) 0.97
Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev (2007) 0.97
Interprofessional relations between doctors and nurses: perspectives from South Wales. J Adv Nurs (2000) 0.96
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant (2006) 0.95
Morphometric analysis of the developing mouse soleus muscle. Am J Anat (1988) 0.95
Screening for tuberculosis in an east London HIV clinic. Int J STD AIDS (1995) 0.95
Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. Hum Mol Genet (1992) 0.95